Background {#Sec1}
==========

CRISPR/Cas adaptive immunity systems confer resistance to invading phages and conjugative plasmids in bacteria and archaea \[[@CR1]--[@CR3]\]. CRISPR/Cas-mediated immunity mechanism involves three steps: adaptation (during which spacers are acquired from the invader genome); processing and biogenesis of CRISPR RNAs (crRNAs); and molecular interference against the invader's genome \[[@CR4], [@CR5]\]. CRISPR/Cas systems have been divided into two main classes: class I, in which multi-effector complexes mediate the interference; and class II, which employs single, multi-domain effectors to mediate the interference. These two classes are further subdivided into six types and 33 subtypes according to the genomic architecture of the CRISPR array and the signature interference effector. For example, class I includes types I, III, and IV and class II includes types II, V, and VI \[[@CR6], [@CR7]\]. Notably, CRISPR/Cas systems of types I, II, and V target the double-stranded DNA of invading phages or conjugative plasmids, but types III and VI target the single-stranded RNA of invading phages, resulting in molecular immunity against invading nucleic acids \[[@CR8]--[@CR11]\].

Using microbial genome data mining and computational prediction approaches to search for previously unexplored class II CRISPR Cas systems has led to the discovery of novel Class II CRISPR systems, including C2c1, C2c2, and C2c3 \[[@CR7]\]. C2c1 and C2c3 contain RuvC-like endonucleases similar to Cpf1 and were therefore classified as Class II type V CRISPR/Cas systems, known as type V-B Cas12b and type V-C Cas12c, respectively \[[@CR12]\]. In contrast to these other Cas nucleases, Class II candidate 2 (C2c2), designated as Cas13a, has unique features not present in other known Cas proteins. Analysis of the Cas13a protein sequence revealed the presence of two higher eukaryotes and prokaryotes nucleotide-binding domains (HEPN), which are exclusively associated with RNase activity \[[@CR13]\]. Cas13a contains two HEPN, which are exclusively associated with RNase activity \[[@CR13]\]. These distinct characteristics of the Cas13a protein raised the enticing possibility that Cas13a works as a single RNA-guided RNA targeting effector.

A recent work characterizing the functionality of Cas13a of *Leptotrichia shahii* (LshCas13a) has shown that the single effector Cas13a protein is indeed a programmable RNA-guided single-stranded RNA (ssRNA) ribonuclease \[[@CR11]\]. Cas13a was shown to provide immunity to a bacteriophage in *Escherichia coli* by interfering with the MS2 lytic ssRNA phage. Cas13a guided by a crRNA containing a 28-nt spacer sequence cleaves target ssRNAs in vitro and in vivo with protospacer flanking sequence (PFS) of A, U, or C. Cas13a catalytic activity is affected by the secondary structure of the target sequence, where Cas13a tends to preferentially cleave at uracil residues of multiple sites within secondary structures formed in the ssRNA targets. Moreover, the two HEPN domains are responsible for the RNA cleavage activity of Cas13a; mutation of putative catalytic arginine residues within both domains abolished the RNA cleavage activity, resulting in a catalytically inactive version of the Cas13a enzyme (dCas13a). However, like dCas9, dCas13a retains its ability to bind specifically to the target RNA and therefore can function as an RNA-guided RNA-binding protein \[[@CR11], [@CR14]\]. Cas13a can tolerate single-base mismatches but not double mismatches in the middle of the crRNA spacer sequence--protospacer base paring, pointing to the presence of a central seed sequence. Importantly, the system demonstrated its ability to be reprogrammed to target specific, non-phage RNAs in vivo by knocking down the expression of the RFP protein in *E. coli*. However, *E. coli* cells expressing RFP and active CRISPR/Cas13a machinery targeting RFP transcript exhibited reduced growth, indicating collateral RNA degradation activity. The collateral Cas13a RNA degradation activities require the successful targeting of the target sequence and the activation of the Cas13a protein. Such collateral targeting could provide a means for engineering programmed cell death for biotechnological applications \[[@CR11]\].

East-Seletsky et al. \[[@CR15]\] have shown that Cas13a exhibits dual, distinct functions in processing of the pre-crRNA and degradation of ssRNA targets. These Cas13a activities would facilitate the design and expression of multiple crRNAs under the control of polymerase II promoters for targeting multiple transcripts. Similar to LshCas13a, LbuCas13a from *Leptotrichia buccalis* is activated by a specific crRNA to target a specific ssRNA sequence, but this activation led also to collateral non-specific activities, leading to cell toxicity \[[@CR15]\]. The study also showed that the collateral cleavage activity of Cas13a could be advantageous to detect and sense the presence of specific transcripts. Building on this idea, a recent study exploited the collateral effect of the promiscuous RNAse activity of Cas13a upon target recognition to develop a diagnostic tool for in vitro detection of RNA, with a single-base mismatch specificity and attomolar sensitivity, demonstrating a wide range of potential utility in diagnostic and basic research applications \[[@CR16]\]. Findings of these studies suggest that Cas13a can function as part of a versatile, RNA-guided RNA-targeting CRISPR/Cas system that holds great potential for precise, robust, and scalable RNA-guided RNA-targeting applications \[[@CR17]\].

Plant RNA viruses are responsible for a significant proportion of commercially important plant diseases, infecting a wide range of plant species and resulting in severe losses in quality and quantity in diverse key crops \[[@CR18], [@CR19]\]. Various transgenic strategies based on the pathogen-derived resistance concept have been applied to engineer virus resistance in many plant species \[[@CR20]\]. For instance, transgenic plants expressing viral genes (e.g. genes encoding viral coat proteins) or RNA sequences of virus origin (to induce RNA interference-mediated resistance) have been shown to confer immunity against viruses from which the genes and RNA sequences were derived \[[@CR21]--[@CR23]\]. In addition, introduction of plant antiviral genes, such as *R* genes, into crop plants has gained prominence as an effective approach to engineer transgenic plants resistant to virus infection \[[@CR24]--[@CR27]\]. Despite the promising potential of these transgenic approaches, many drawbacks have limited their applications in agriculture \[[@CR28]--[@CR30]\].

*Potyviruses* are plant-infecting viruses that belong to the *Potyvirus* genus, one of the largest groups of plant viruses besides the *Begomoviruses. Potyviruses* represent an economically important group of pathogens capable of infecting and causing a serious damage to a wide range of crop plants. Members of the *Potyviruses*, such as *Turnip mosaic virus* (TuMV), possess long, filamentous particles that are 700--750 nm long, harboring a positive-stranded RNA genome of about 10,000 nucleotides. The ssRNA genome encodes a single long open reading frame (ORF) flanked by terminal untranslated regions. The RNA genome is translated into a single large polyprotein, which is subsequently cleaved by virus-encoded proteinases to yield at least ten functional proteins \[[@CR31]\].

Here, we sought to investigate the possibility of adopting the CRISPR/Cas13a system for interference against RNA viruses in plants and, to that end, we engineered the CRISPR/Cas13a RNA interference system for *in planta* applications. Our study reveals that CRISPR/Cas13a catalytic activities resulted in interference against TuMV-GFP in transient assays and stable overexpression lines of *Nicotiana benthamiana* and that Cas13a can process long pre-crRNA transcripts into functional crRNAs, resulting in TuMV interference. Thus, our study demonstrates that the CRISPR/Cas13a system is portable to plant species for RNA virus interference, thereby opening myriad possibilities for research and applied uses in plants and other eukaryotic species.

Results {#Sec2}
=======

Engineering CRISPR/Cas13a machinery for *in planta* expression {#Sec3}
--------------------------------------------------------------

Because CRISPR/Cas13a defends bacterial cells against invading RNA viruses, we attempted to test the feasibility and portability of the CRISPR/Cas13a system to provide molecular immunity against RNA viruses in plants. To this end, we selected the potyvirus *Turnip mosaic virus* (TuMV), of the family *Potyviridae*, as a target for CRISPR/Cas13a. A recombinant TuMV (TuMV-GFP) expressing GFP was used to provide an easy-to-monitor system for virus infection, replication, and spread, thereby facilitating the assessment of the interference activity of CRISPR/Cas13a system against the RNA virus.

To engineer plants that express the CRISPR/Cas13a machinery, we codon-optimized the *Leptotrichia shahii Cas13a* (*LshCas13a*, WP_018451595.1) nucleotide sequence for expression in plants and custom synthesized four overlapping fragments to assemble the construct, which we dubbed plant-codon optimized *Cas13a* (*pCas13a*). The four overlapping fragments of *pCas13a* were assembled by unique restriction enzymes to generate a full-length clone flanked by attL1 and attL2 recombination sites, a nuclear localization signal fused to the C-terminus of the protein, and a 3x-HA tag fusion at the N-terminus to facilitate protein detection. Next, *pCas13a* was sub-cloned into the *pK2GW7* destination binary vector via Gateway recombination reaction to generate *pK2GW7:pCas13a* over-expression clones driven by the *Cauliflower mosaic virus* (CaMV) 35S promoter (Fig. [1a](#Fig1){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Figure S1A). Subsequently, the binary *pCas13a* clone was introduced into *Agrobacterium tumefaciens* via electroporation. Next, Agrobacterium GV3101 cultures harboring the *35S::pCas13a* binary clone were used for transient expression in *N. benthamiana* via agro-infection or for generation of transgenic plants overexpressing the pCas13a protein (pCas13a-OE). We confirmed the pCas13a expression in transient assays in *N. benthamina* leaves and in permanent lines over-expressing pCas13a. Our western blotting results with anti-HA tag antibody demonstrated that the pCas13a clone was expressed in plants and the correct protein size was detected (Fig. [1b](#Fig1){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Figure S1B).Fig. 1Reconstitution of the CRISPR/Cas13a machinery in plants. **a** Schematic assembly of the plant codon-optimized *Cas13a* (*pCas13a*). *pCas13a* was custom synthesized as four fragments. The F1 (with attL1 and 3x-HA), F2, F3, and F4 (with nls and attL2) fragments were assembled in the cloning vector using a restriction-ligation system. The respective restriction enzymes sites are represented on the *top*. By LR reaction, *pCas13a* was moved into the Gateway-compatible binary vector *pK2GW7* to make *pK2GW7-pCas13a*. HA human influenza hemagglutinin epitope tag, nls nuclear localization signal, attL1 and attL2, Gateway cloning recombination sites. **b** Confirmation of pCas13a expression in transgenic lines. Total protein was extracted from three independent lines of *N. benthamiana* transformed with *pK2GW7-pCas13a*. Anti-HA antibody was used to detect HA-tagged pCas13a. The *arrow* indicates the presence of pCas13a. Wild type (WT) was used as a negative control. **c** The TuMV-GFP genome with selected targets. The arrowheads indicate the four selected sites. The lower panel represents the target RNA sequences paired with their respective crRNAs. PFS protospacer flanking site. **d** Expression of the crRNA from the TRV system. The repeat-guide DNA sequences were cloned under the PEBV promoter in RNA2 of TRV for constitutive and systemic expression. **e** Diagrammatic representation of the pCas13--crRNA--target complex. The targeting complex pCas13a--crRNA (repeat sequence-n28, guide RNA-n28) bound to the RNA target n28 for interference

Next, to target the TuMV-GFP virus, we designed and constructed crRNAs complementary to sequences of four different regions of TuMV-GFP genome, including two targets in *GFP* (GFP1 and GFP2), and the helper component proteinase silencing suppressor (*HC-Pro*) and coat protein (*CP*) sequences (Fig. [1c](#Fig1){ref-type="fig"}). We engineered the RNA2 genome of *tobacco rattle virus* (TRV) to transiently and systemically express crRNAs under the *Pea early browning virus* (PEBV) promoter, as previously described (Fig. [1d](#Fig1){ref-type="fig"}) \[[@CR32]\]. These crRNAs can be used to test the functionality of CRISPR/pCas13a in transient and stable assays.

CRISPR/pCas13a interferes with TuMV-GFP *in planta* {#Sec4}
---------------------------------------------------

To test whether the CRISPR/pCas13a could interfere with TuMV-GFP, we first performed transient assays in *N. benthamiana* leaves. Successful interference with the TuMV-GFP genome would result in attenuated replication and spread of the virus, which can be measured by monitoring the level and spread of the virus-mediated GFP expression to systemic leaves during the course of the infection. Mixed *Agrobacterium* cultures carrying the binary *pK2GW7:pCas13a* clones, TRV RNA1, and the engineered TRV RNA2 genome harboring crRNAs against one of the four different TuMV-GFP genome targets (*HC-Pro*, coat protein \[*CP*\], *GFP* target 1 \[*GFP1*\], *GFP* target 2 \[*GFP2*\]), as well as TuMV-GFP infectious clones co-delivered into *N. benthamiana* leaves via agro-infection. In addition, a non-specific crRNA (ns-crRNA) with no sequence similarity to the TuMV-GFP genome was used as a control. The interference activity of the CRISPR/pCas13a system against the TuMV-GFP virus was assessed at seven days post infiltration (dpi) by visualizing the GFP signal in the plant systemic leaves under ultraviolet (UV) light. We observed a reduction of \~ 50% in the level of GFP signal in the systemic leaves of plants with crRNAs targeting the *HC-Pro* and *GFP2* sequences. In addition, a low, but detectable reduction in the GFP signal was observed with the *CP* and *GFP1* crRNAs compared to the control, whereas no difference in the GFP signal was observed in the wild-type (WT) *N. benthamiana* plants co-infiltrated with the TRV expressing ns-crRNAs, targeted crRNAs, and TuMV-GFP but not *pK2GW7:pCas13a* clones (Additional file [1](#MOESM1){ref-type="media"}: Figure S2A, B). These initial results indicated the functionality and the ability of the CRISPR/pCas13a to interfere with the TuMV-GFP virus *in planta*.

We next assessed the interference activity of CRISPR/Cas13a against the TuMV-GFP in transgenic *N. benthamiana* plants constitutively expressing pCas13a protein (pCas13a-OE) under the control of CaMV35S promoter. These transgenic plants were generated via *Agrobacterium*-mediated transformation of *pK2GW7:pCas13a* clones into WT *N. benthamiana* plants; and the pCas13a protein expression was confirmed by western blotting (Fig. [1b](#Fig1){ref-type="fig"}). The crRNAs targeting the *HC-Pro*, *CP*, *GFP1*, or *GFP2* sequences were delivered into pCas13a-OE plants via the TRV system and expressed under the control of the *PEBV* promoter. In addition, the pCas13-OE plants were co-infiltrated with infectious TuMV-GFP clones via agro-infection. At 7 dpi, the virus-expressed GFP signals were monitored in systemic leaves of the infected pCas13a-OE plants. A substantial reduction, up to 50%, in the GFP intensity was observed with crRNAs targeting the *HC-Pro* and *GFP2* targets. However, consistent with transient assay, crRNAs targeting the *CP* and *GFP1* sequences exhibited only a moderate reduction in the GFP intensity when compared with the ns-crRNA or the empty vector control (Fig. [2a](#Fig2){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S3).Fig. 2The pCas13a--crRNA complex interferes with TuMV-GFP *in planta*. **a** pCas13a mediates interference with the GFP-expressing TuMV virus in plants. *N. benthamiana* plants expressing pCas13a were infiltrated with TRV expressing crRNAs and TuMV-GFP. At 7 dpi, plants were imaged under UV light for GFP. The GFP signal of the plants having target crRNAs were compared to plants having no crRNA or a ns-crRNA. **b** GFP protein detection was used to validate the TuMV-GFP interference. Protein blots from (a) were developed with anti-GFP antibody. The *arrow* indicates the size of the GFP band. **c** Northern blot confirms that Hc-crRNA and GFP2-crRNA give better interference with TuMV. RNA blots from (a) were probed with a DIG-labeled TuMV complementary (250-nt) RNA fragment and detected with anti-DIG antibody. The *arrow* indicates the accumulation of the TuMV RNA genome. In (b) and (c) the *lower panels* were used as loading controls

To validate the observed reduction in the GFP signal, western blotting was used to assess the virus levels in systemic leaves. We found that plants with crRNAs targeting *HC-Pro* or *GFP2* sequences exhibited the largest reduction of GFP levels compared to crRNAs targeting *CP* or *GFP1* target sequences or the controls, corroborating the results obtained from the analysis of the GFP signals (Fig. [2b](#Fig2){ref-type="fig"}).

To further validate the CRISPR/pCas13a-mediated interference with the RNA genome of TuMV-GFP, total RNA from systemic leaves of the infected plants were isolated and northern blotting was performed to detect the accumulation of the TuMV genome. Consistent with the level of the GFP protein, the northern blots showed a clear reduction in the accumulation of the TuMV-GFP RNA genome using the crRNAs targeting *HC-Pro* or *GFP2* (Fig. [2c](#Fig2){ref-type="fig"}), indicative of targeted degradation of the TuMV-GFP genomic RNA via CRISPR/pCas13a. Importantly, the ns-crRNA showed no interference activity, in contrast to the specific crRNAs, thus validating the specificity and programmability of CRISPR/pCas13a for specific RNA targeting in plants.

pCas13a processes poly-crRNA into functional crRNAs {#Sec5}
---------------------------------------------------

Cas13a has been reported to process its own pre-crRNA \[[@CR15]\]; therefore, we tested whether pCas13a could process pre-crRNAs in plants. This is of great importance since such ability would enable the generation of multiple functional crRNAs for multiplexed targeting of the same virus or for simultaneous targeting of multiple RNA and/or DNA viruses in plants. Therefore, we designed CRISPR arrays harboring 28-nt targeting the *HC-Pro*, *GFP1*, and *GFP2* sequences of the TuMV-GFP RNA genome flanked by 28-nt direct repeats (poly-crRNA) (Fig. [3a](#Fig3){ref-type="fig"}). In addition, we designed CRISPR arrays harboring ns-poly-crRNA. These CRISPR arrays were delivered into WT plants (lacking pCas13a) and pCas13a-OE plants via the TRV system to be systematically expressed as long pre-crRNA transcripts, mimicking the endogenous expression of pre-crRNAs in prokaryotes. We analyzed the processing activity of pCas13a by performing northern blotting using probes against the direct repeat regions within the pre-crRNA, with the ultimate goal of detecting the presence of the mature (processed) crRNAs that would indicate the successful generation of mature crRNAs. The northern blotting results showed considerable accumulation of small RNA products in both specific and non-specific poly-crRNAs, consistent with the expected size of the mature crRNAs as compared with the size of the synthetic versions (s-crRNA) of the mature crRNA product (Fig. [3b](#Fig3){ref-type="fig"}).Fig. 3pCas13a-processed poly-crRNA mediates interference with TuMV-GFP. **a** Schematic of the cleavage of poly-crRNA by pCas13a. *Rectangles* denote the spacer sequences and *solid lines* denote repeat elements. The predicted cleavage sites are depicted. **b** Northern blot for pCas13a-mediated cleavage of poly-crRNA. RNA blot from two independent transgenic lines of pCas13a (L-9 and L-6) infiltrated with TRV RNA1 and RNA2 expressing specific poly-crRNA and a ns-poly-crRNA and TuMV-GFP. The RNA blot was probed and detected with a DIG-labeled 28-nt RNA fragment against the repeat sequence. The *arrow* indicates the processed crRNA (56 nt) in L-9 from both ns-poly-crRNA and poly-crRNA compared to WT *N. benthamiana*. In L-6, the processed crRNA level from poly-crRNA remained under the detection level. The synthetic crRNA (56 nt) was used as an experimental control. **c** GFP signal data demonstrating the poly-crRNA-mediated interference against TuMV-GFP. pCas13a transgenic *N. benthamiana* plants infiltrated with TRV expressing poly-crRNA (three crRNAs) and TuMV-GFP were imaged under UV light for GFP at 7 dpi. The GFP signal of the plants expressing poly-crRNAs were compared to plants expressing ns-poly-crRNA or empty vector control. **d** GFP quantification of poly-crRNA-mediated viral interference. The GFP signal (*n* = 5) data were used for the generation of a percentile graph. The GFP signal of the plants inoculated with TuMV-GFP and empty vector control were used as a reference. **e** Northern blot showing the poly-crRNA-based interference against TuMV-GFP. RNA blots were probed with the DIG-labeled RNA fragment and developed with anti-DIG antibody. The arrow indicates the accumulation of the TuMV RNA genome. **f** Western blot to confirm the TuMV-GFP interference by poly-crRNA. Protein blots from the poly-crRNA and ns-poly-crRNA were detected for GFP with anti-gfp antibody. ns-poly-crRNA and plants inoculated with only TuMV-GFP were used as control. In (**e**) and (**f**), the *lower panels* were used as loading controls

Considering the possibility that the processed "mature" crRNAs would assemble with pCas13a to form active pCas13a--crRNA complexes, we investigated whether the generated mature crRNAs are functional and therefore would allow efficient targeting of the TuMV-GFP RNA genome. The pCas13-OE plants were agro-infiltrated with TRV expressing either the poly-crRNA or the ns-poly-crRNAs and were challenged with the TuMV-GFP virus. The viral GFP signal was determined in systemic leaves at 7 dpi. Strikingly, we detected a significant reduction in the intensity and spread of the viral GFP signal in plants with poly-crRNA. On the other hand, no reduction in the GFP signal was observed with the ns-poly-crRNA relative to the control (Fig. [3c](#Fig3){ref-type="fig"}). A quantitative evaluation of the GFP signal revealed an average reduction in the GFP signals of about 50% with the poly-crRNA, whereas no significant reduction was detected with the ns-poly-crRNA (Fig. [3d](#Fig3){ref-type="fig"}). Furthermore, results of northern blotting showed a clear reduction in the TuMV-GFP RNA genome level in the case of the poly-crRNA, compared to the undetectable reduction of the TuMV-GFP with the ns-poly-crRNA (Fig. [3e](#Fig3){ref-type="fig"}). In addition, western blotting demonstrated a reduction in the protein level of the virus-expressed GFP in plants with the poly-crRNA compared with ns-poly-crRNA, consistent with the results of the GFP signal intensity measurement and northern blot (Fig. [3f](#Fig3){ref-type="fig"}). These results indicate the ability of pCas13a to process pre-crRNA transcripts and generate functional crRNAs capable of guiding pCas13a to recognize and interfere with the target RNA virus in plants.

Discussion {#Sec6}
==========

CRISPR/Cas systems provide bacteria and archaea with immunity to fend off invading nucleic acids; and thus provide synthetic bioengineers with rich resources to build systems to edit and regulate the genome and epigenome; and to modulate, modify, and monitor the transcriptome. Therefore, CRISPR/Cas systems can be harnessed for functional biology, biotechnology, and genetic medicine. Here, we harnessed CRISPR/Cas13a to selectively interfere with the TuMV RNA virus. Our data demonstrate that CRISPR/Cas13a can mediate molecular interference against a plant RNA virus. Targeting different viral genomic regions for degradation resulted in reduced levels of GFP, coupled with the reduction in the accumulation of the TuMV-GFP RNA genome in systemic leaves. These findings indicate the attenuation of the TuMV virus replication and spread, corroborating the effectiveness of CRISPR/pCas13a in targeting and interfering with the TuMV RNA viruses in plants.

In this study, we observed that virus interference was most efficient with crRNAs targeting sequences within the *HC-Pro* and *GFP2* sequences. However, crRNAs targeting the *CP* or *GFP1* target sequences were less effective, suggesting that, among other unexplored factors, secondary structures within the target TuMV-GFP RNA or the presence of RNA binding proteins might influence the accessibility and thus the activity of the pCas13a on the target RNA. This observation is consistent with other studies that have shown that the activity of Cas13 is highly governed by RNA target accessibility. For example, Abudayyeh et al. have characterized the LshCas13a activity in its native environment and have shown that the most effective crRNAs were found to be clustered and closer together in regions of strong interference, suggesting that target RNA accessibility, indeed, impacts the Cas13a activity \[[@CR11]\]. In addition, similar conclusions were drawn with other Cas13 variants, including the LwaCas13a \[[@CR33]\] and BzCas13b \[[@CR34]\] CRISPR systems. These findings suggest that careful selection of RNA target sites as well as exploration of various crRNAs efficiency might be essential to maximize Cas13a activity and to the success of the Cas13-mediated RNA interference. Moreover, we cannot exclude that there may be other mechanisms at play controlling the targeting accessibility and efficiencies of CRISPR/Cas13 systems which require further studies. It is worth noting that different approaches may be applied to improve the targeting and interference activities of CRISPR/Cas13a system against RNA viruses including: (1) multiplex targeting of the virus ssRNA genome; (2) the use of other Cas13 variants with robust RNA-guided ribonuclease activity; and (3) the use of certain protein stability fusions such as msfGFP, which have been fused to Cas13 proteins to enhance their stability and catalytic activity \[[@CR33]\].

It has been shown that using ≤ 54-nt complementary sequence in the TRV system does not activate post-transcriptional gene silencing in plants \[[@CR35]\]. However, to exclude the possibility that the 28-nt (spacer sequence of crRNA) can activate the RNAi for the observed TuMV-GFP interference, TuMV-GFP and TRV with crRNAs were co-infiltrated to the WT *N. benthamiana* plants. Our results (Additional file [1](#MOESM1){ref-type="media"}: Figure S2A, lower panel) clearly indicate that the expression of only 28-nt spacers did not lead to any silencing of TuMV-GFP in WT *N. benthamiana*, confirming that the observed interference is pCas13a-dependent.

Catalytically active Cas13a can process long pre-crRNAs in vitro and in vivo. Importantly, *in planta*, the absence of the processed mature crRNA product in the WT plants, in contrast to pCas13a-OE plants, provides corroborating evidence that the generation of the mature crRNA is attributed to the presence of pCas13a, consistent with the known role of Cas13a in processing pre-crRNA transcripts \[[@CR15]\]. Mature crRNA detection is lower in the presence of its target than the ns-poly-crRNA, probably due to the differential crRNA stability after targeting. Previously different strategies (tRNA and ribozymes) were adopted for multiplex targeting and interference of DNA virus \[[@CR36], [@CR37]\]. However, the ability of pCas13a to process the poly-crRNA into individual crRNAs permits us to use the pCas13a native potential to produce multi-crRNA from a single poly-crRNA for viral interference. Subsequently, the results obtained from the targeting of TuMV-GFP RNA with a single crRNA (Fig. [2](#Fig2){ref-type="fig"}) and poly-crRNA (Fig. [3c--f](#Fig3){ref-type="fig"}) show analogous patterns of GFP signal, suggesting that the processed crRNA are functional and pCas13a-crRNA complexes interfere with the TuMV-GFP genome. The observed recovery from virus symptoms in this study shows that the CRISPR/pCas13a system has promise for engineering plants for resistance against plant RNA viruses.

Several questions remain relating to the mechanisms of RNA recognition and subsequent activation of the ribonuclease activities on target and non-target ssRNAs. Liu et al. reported that upon target RNA binding and subsequent activation of the ribonuclease activity, Cas13a exhibits indiscriminate degradation of non-target RNAs leading to promiscuous activity \[[@CR38]\]. Surprisingly, Cas13a overexpression plants appear similar to the WT plants and introduction of crRNAs with virus target did not lead to cell death. Because promiscuous and collateral RNA-degradation activities may cause cellular toxicity and lead to cell death, our study reveals that such robust promiscuous activity is lacking or too low to be detected in plant cells or eukaryotes in general. While preparing this manuscript, another study about the ability of the Cas13a variants to target messenger RNA in human cells and plant protoplast was published by Abudayyeh et al. \[[@CR33]\], observing no promiscuous activity of Cas13a in eukaryotic cells. Further studies are needed using different Cas13a variants and exhaustive crRNAs against viral and endogenous RNA targets.

Future work would focus on Cas13a variants that exhibit robust ribonuclease activity. Alternatively, the RNA-targeting and RNA-binding functions could be used for selective degradation of targets through the use of other robust ribonuclease domains fused to the Cas13a backbone.

Conclusions {#Sec7}
===========

Our findings show that Cas13a is an RNA-guided ribonuclease that can be programmed to target and degrade viral RNA genomes, thereby providing a promising and an effective tool for a variety of RNA manipulations and specifically interference against RNA viruses in plants and in eukaryotic cells in general.

Methods {#Sec8}
=======

Design and construction of CRISPR/Cas13 machinery for *in planta* expression {#Sec9}
----------------------------------------------------------------------------

We designed a pCas13a protein including 3x-HA, NLS, attL1, and attL2 sites. The nucleotide sequence of *pCas13* (Additional file [2](#MOESM2){ref-type="media"}: Sequence S1, S2) was designed as four overlapping fragments with unique restriction enzymes to facilitate sequential cloning and assembly into a single fragment. These four fragments were custom synthesized into the pUC19(-MCS) plasmid by Blue Heron Biotech gene synthesis services (Blue Heron Biotech, Bothell, WA, USA). The first fragment (fragment 1) is preceded by the attL1 sequence and the last fragment (F4) ends with the attL2 sequence for subsequent LR Gateway recombination reaction. To assemble the four fragments into a single fragment, fragments 1 and 2 were assembled by restriction digestion with Xba1 and PpuM1 enzymes and fragments 3 and 4 were assembled with pPuM1 and Not1 to generate pUC19-(F1 + F2) and pUC19-(F3 + F4), respectively. Subsequently, the pUC19-F3 + F4 clone was sub-cloned into pUC19-F1 + F2 using Avr2 and NotI enzymes to generate a single clone with the complete and in-frame sequence of *pCas13a*. The *pUC19-pCas13a* construct was confirmed by Sanger sequencing using overlapping primers. Next, we sub-cloned *pCas13a* into the *pK2GW7* binary vector using LR Gateway recombination cloning to generate pK2GW7-pCas13a (Additional file [3](#MOESM3){ref-type="media"}: Map S1) for expression in plants under the control of the 35S promoter.

The crRNAs were designed as primer dimers (Additional file [3](#MOESM3){ref-type="media"}: Table S2) with overhang and were cloned under PEBV promoter in TRV RNA2 by XbaI and BamHI (Additional file [2](#MOESM2){ref-type="media"}: Sequence S4--7).

The poly-crRNA and ns-poly-crRNA were custom-synthesized in pUC19 with unique sites (BamHI and SacI). Both the poly-crRNA and the ns-poly-crRNAs were cloned to the TRV RNA2 by BamHI and SacI.

Plant material {#Sec10}
--------------

*N. benthamiana* plants expressing Cas13a were regenerated using the previously developed protocol \[[@CR32]\]. The *pK2GW7-pCas13a* construct was used to generate plants (*N. benthamiana* or resistant) for programming resistance to TuMV (Additional file [2](#MOESM2){ref-type="media"}: Sequence S3, Map S2 and Additional file [3](#MOESM3){ref-type="media"}: Table S1). All plants were selected on 50 mg kanamycin in ½ Murashige-Skoog agar media.

Agro-infiltration of *N. benthamiana* leaves and GFP imaging {#Sec11}
------------------------------------------------------------

Constructs, harboring the TuMV-GFP infectious clone, TRV RNA2 empty, or containing crRNA under PEBV promoter, TRV RNA1, were individually electroporated into *Agrobacterium tumefaciens* strain GV3101. Overnight-grown single colonies in selective medium were centrifuge and suspended, in infiltration medium (10 mM MES \[pH 5.7\], 10 mM CaCl~2~, and 200 μM acetosyringone), and incubated at ambient temperature for 2 h. For infiltration into Cas13a-OE plants, cultures were mixed at an OD~600~ ratio of 0.05:1:1 (TuMV-GFP, TRV RNA2, TRV RNA1) and infiltrated into three- to four-week-old leaves of *N. benthamiana* Cas13a-OE plants with a 1-mL needleless syringe. GFP expression was observed at 3, 7, and 10 dpi using a hand-held UV light. Photos were taken with a Nikon camera both in normal light and under UV light. GFP signal quantifications were done using ImageJ software. Leaves samples were collected at 7 and 15 dpi for molecular analyses.

Immunoblot analysis {#Sec12}
-------------------

Total proteins were extracted from 100 mg of sample using extraction buffer (100 mM Tris-Cl pH8, 150 mM NaCl, 0.6% IGEPAL, 1 mM EDTA, 3 mM DTT with protease inhibitors, PMSF, leupeptin, aprotinin, pepstatin, antipain, chymostatin, Na~2~VO~3~, NaF, MG132, and MG115. Proteins were separated on a 10% polyacrylamide gel. Immunoblot analysis was carried out using mouse α-GFP (1:2000; Invitrogen) for TuMV GFP and rat α-HA (1:500) antibody for pCas13a. The antigens were detected by chemiluminescence using an ECL-detecting reagent (Thermo Scientific).

RNA isolation and northern blot analysis {#Sec13}
----------------------------------------

Total RNA was extracted from virus-infected plants using the Direct-zol RNA MiniPrep Plus (Zymo Research) according to the manufacturer's recommendations. For each sample, 10--15 μg of RNA was separated on a denaturing 2% agarose gel, blotted on a Hybond-N^+^ (GE Healthcare) membrane and hybridized with a DIG-labelled probe. For virus expression analysis, a DIG-labelled RNA probe was synthesized using DIG Northern Starter Kit (Roche) and manufacturer's instructions were followed. For crRNA detection, a 5'-end DIG-labelled oligonucleotide (IDT) was used. DIG application manual (Roche) was followed for capillary transfer, hybridization, and detection. Northern blots were repeated in three independent experiments with the same results.
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Additional file 1: Figure S1.Confirmation of *pCas13a* expression *in planta*. **Figure S2.** pCas13a-mediated interference with TuMV-GFP *in planta*. **Figure S3.** GFP quantification of TuMV-GFP interference in transgenic pCas13a-OE plants. (PDF 1393 kb) Additional file 2: Sequence S1:pCas13a amino acid sequence (3xHA-pCas13a-nls). **Sequence S2:** pCas13a full-length plant codon optimized DNA sequence (3x-HA-pCas13a-nls) Map S1: pCas13a sequence in pK2GW7-pCas13a (pK2GW7-3xHA-pCas13a-nls). **Sequence S3:** TuMV-GFP full-length sequence with target sequences in different colors. Map S2: Map of TuMV-GFP. **Sequence S4:** Cas13a-repeat-cRNA-TuMV-GFP-GFP-target 1 sequence (A), map (B) and its complex with targeting region in TuMV GFP genomic region (C). **Sequence S5:** Cas13a-repeat-cRNA-TuMV-GFP-GFP-T2 sequence (A), map (B), and its complex with targeting area in TuMV GFP genomic region (C). **Sequence S6:** Cas13a-repeat-cRNA-TuMV-GFP-HC-Pro-T1 sequence (A), map (B), and its complex with HC-pro targeting region in TuMV (C). **Sequence S7:** Cas13a-repeat-cRNA-TuMV-GFP-Cp-Pro-T1 sequence (A), map (B), and its complex with Capsid protein targeting region in TuMV. (DOCX 414 kb) Additional file 3: Table S1:TuMV genome description. **Table S2:** Primers used in this study. (DOCX 21 kb)
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